GE HealthCare tops Q4 profit estimates, offers full-year guidance

GE HealthCare Technologies Inc (NASDAQ: GEHC) posted better-than-expected earnings and adjusted EBIT for the fourth quarter, while revenue marginally missed expectations.

The health technology company reported Q4 earnings per share (EPS) of $1.45, surpassing consensus estimates of $1.26. The company's revenue rose 2% year-over-year to $5.32 billion, nearly in line with the expected $5.33 billion.

Adjusted EBIT rose 19% year-on-year to $994 million, ahead of the $905.9 million forecast.

“We were pleased with the strong momentum in orders, backlog and book-to-bill that we saw in the fourth quarter. We also continued to deliver revenue growth driven by demand in our Advanced Visualization Solutions and Pharmaceutical (TADAWUL:2070) Diagnostics businesses, with overall strength in the U.S., and robust margin expansion and earnings growth," said GE HealthCare President and CEO Peter Arduini.

"Customer interest in new, differentiated products contributed to orders growth and recurring revenue in the year. We remain committed to our precision care strategy for growth, supported by innovation, productivity initiatives, and commercial execution.”

For fiscal 2025, GE HealthCare expects EPS between $4.61 and $4.75, compared to the consensus estimate of $4.65.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Analyst draws dot-com parallels as AI trade narrows market leadership
• Pfizer reaffirms 2026 guidance after CFO transition news